Unknown

Dataset Information

0

The proteostatic network chaperome is downregulated in F508del homozygote cystic fibrosis.


ABSTRACT:

Background

CF patients demonstrate clinical heterogeneity and much remains unknown about how to risk stratify individuals for disease progression.  The most common cystic fibrosis mutation, F508del, is a protein folding mutation that has been shown in vitro to negatively affect proteostasis and CFTR transcription. Since CFTR is expressed in the nasal epithelium, we hypothesized that by using unbiased transcriptomics we could gain clinically relevant insights about differential gene expression and heterogeneity in CF patients as well as assess proteostatic dysfunction in the nasal epithelium.

Methods

Using nasal curettage and RNA-seq we assessed differential gene expression in F508del homozygotes compared to healthy volunteers. Gene set enrichment analysis was performed using a list of known chaperones. Pilot and validation cohorts were studied.

Results

PCA analysis and gene expression heatmaps exhibited greater heterogeneity among CF than healthy volunteers. Differentially expressed genes were enriched for the downregulation of ciliary/microtubular genes and the upregulation of inflammatory/immune response genes in F508del homozygotes compared to healthy volunteers. Gene set analysis identified negative enrichment for chaperone genes and decreased CFTR transcription in the F508del homozygotes. We also found preliminary evidence for the recently identified ionocyte in the nasal specimens.

Conclusion

CF patients homozygous for F508del demonstrate heterogeneous gene expression profiles, proteostatic dysregulation, and reduced CFTR transcription. Larger studies are needed to determine whether nasal epithelial gene transcription profiles can be leveraged for insights into disease heterogeneity.

SUBMITTER: Sala MA 

PROVIDER: S-EPMC8900221 | biostudies-literature | 2021 Mar

REPOSITORIES: biostudies-literature

altmetric image

Publications

The proteostatic network chaperome is downregulated in F508del homozygote cystic fibrosis.

Sala Marc A MA   Alexander Michael M   Khuder Basil B   Politanska Yuliya Y   Abdala-Valencia Hiam H   Budinger G R Scott GRS   Liu Jing J   Jain Manu M   Reyfman Paul A PA  

Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society 20210123 2


<h4>Background</h4>CF patients demonstrate clinical heterogeneity and much remains unknown about how to risk stratify individuals for disease progression.  The most common cystic fibrosis mutation, F508del, is a protein folding mutation that has been shown in vitro to negatively affect proteostasis and CFTR transcription. Since CFTR is expressed in the nasal epithelium, we hypothesized that by using unbiased transcriptomics we could gain clinically relevant insights about differential gene expre  ...[more]

Similar Datasets

| S-EPMC5768901 | biostudies-literature
2018-07-31 | GSE101641 | GEO
| S-EPMC7227803 | biostudies-literature
2020-03-26 | GSE136371 | GEO
| S-EPMC4571083 | biostudies-literature
| S-EPMC4264759 | biostudies-literature
| S-EPMC10761587 | biostudies-literature
| S-EPMC5461999 | biostudies-literature
| S-EPMC3463858 | biostudies-literature
| S-EPMC5821210 | biostudies-literature